Intensity-modulated radiation therapy for definitive treatment of cervical cancer: a meta-analysis

Table 1 Characteristics of all the included studies

Author	Year	Country	Study design	Stage	Treatment	Patients (n)	Median age (range)	RT doses (Gy)	Chemotherapy
Naik et al.	2016	India	Prospective	IIA-IIIB	IMRT	20	48(28–70)	50	cisplatin
Naik et al.	2016	India	Prospective	IIA-IIIB	3D	20	45(30–75)	50	cisplatin
Wu et al.	2016	Taiwan.	Retrospective	IB1-IVB	IMRT	30	80.5 (75–88)	45–50.4	cisplatin
Wu et al.	2016	Taiwan.	Retrospective	IB1-IVB	2D/3D	30	77.8 (75–88)	45–50.4	cisplatin
Ganhdi et al.	2013	India	Prospective	IIB-IIIB	IMRT	22	50(36–65)	50.4	cisplatin
Ganhdi et al.	2013	India	Prospective	IIB-IIIB	2D	22	45(36–65)	50.4	cisplatin
Chen et al.	2013	Taiwan	Retrospective	IB2-IIIB	IMRT	83	54	45	cisplatin
Chen et al.	2013	Taiwan	Retrospective	IB2-IIIB	2D/3D	237	54	45	cisplatin
Du et al.	2012	China	Retrospective	IIB-IIIB	IMRT	60	52(31–74)	45–50	cisplatin
Du et al.	2012	China	Retrospective	IIB-IIIB	2D	62	55(26–77)	45–50	cisplatin
Kidd et al.	2010	USA	Prospective	IA2-IVB	IMRT	135	52	50	cisplatin
Kidd et al.	2010	USA	Prospective	IA2-IVB	2D/3D	317	52	50	cisplatin

n number of patients, RT Radiotherapy, 2D Two-dimensional, 3D Three-dimensional, IMRT Intensity modulated RT